Immune Regulation

Immune Regulation

Immune Regulation

Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune system for long-term remission.
Founded
2011
Raised
$54.1M
Follow us
Latest funding
£40,600,000
Venture capital (Series B) - 2020
24 Haymarket Morningside Venture Investments Metellus
Team Size
1–10
Employees
£40,600,000 Venture capital (Series B)
DealStreetAsia

Morningside Ventures leads Series B funding in biotech firm Immune Regulation

FinSMEs

Immune Regulation Raises £40.6M in Series B Equity Financing